This content is machine translated Epilepsy Seizures after a stroke: when to treat, for how long and with what? Acute symptomatic post-stroke seizures generally do not require long-term therapy and the current recommended time limit in guidelines to differentiate epilepsy after stroke is 7 days. Validated tools, such as… CME-Test
View Post 20 min This content is machine translated Alzheimer Update on Alzheimer’s diagnosis: focus on cerebrospinal fluid and blood-based biomarkers Despite the frequency and significance of Alzheimer’s disease, in many cases it is not diagnosed or only diagnosed at an advanced stage of the disease, which considerably limits the treatment… CME-Test
View Post 15 min This content is machine translated Amyotrophic lateral sclerosis Update on diagnostics and therapy In addition to standard care for all forms of ALS, there has been significant progress, particularly for monogenetic forms of ALS, thanks to the development of specific gene-based treatment methods,… CME-Test
View Post 18 min This content is machine translated Irritable Bowel Syndrome Guideline-based therapy of IBS according to the biopsychosocial model The biopsychosocial model considers various somatic and psychosocial factors within the pathophysiology of IBS and integrates their multifaceted interaction processes. In addition, therapeutic starting points can be identified and implemented… CME-Test
View Post 3 min This content is machine translated Lennox-Gastaut syndrome Unmet need with a significant burden of disease New data presented at the 15th European Epilepsy Congress show long delays in the diagnosis of Lennox-Gastaut syndrome (LGS) in Europe and a significant burden of disease due to seizure…
View Post 4 min This content is machine translated Parkinson's Pathophysiology, classification and effective treatment strategies Parkinson’s disease is clinically defined by the main motor symptoms resulting from nigrostriatal degeneration. However, it is now assumed that the disease usually consists of several pathologies. What new findings…
View Post 7 min This content is machine translated Multiple sclerosis Current treatment management of relapsing-remitting MS Various therapeutic strategies are available for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologic agents. Although each of these therapies reduces relapse frequency and…
View Post 4 min This content is machine translated MCI and dementia Ginkgo biloba extract as an add-on scores well in cohort study The results of a retrospective cohort study with data from over 500 patients indicate that the use of a proprietary Ginkgo biloba extract in combination with an acetylcholinesterase inhibitor and/or…
View Post 11 min This content is machine translated Parkinson's disease and movement disorders Optimized therapy management for a better quality of life The International Parkinson and Movement Disorder Society (MDS) brings together thousands of clinicians, researchers, trainees and industry supporters each year who are interested in current research and approaches to the…
View Post 5 min This content is machine translated Rare diseases Donnai-Barrow syndrome This very rare syndrome is caused by mutations in the LRP2 gene, which codes for megalin, and is inherited in an autosomal recessive manner. It is characterized by craniofacial features…
View Post 7 min This content is machine translated Phytotherapy for Alzheimer's disease Herbal approaches to the treatment of a neurodegenerative disease Alzheimer’s disease (AD) is one of the most commonly diagnosed neurodegenerative diseases worldwide and the leading cause of dementia. Alzheimer’s disease affects 50–70% of dementia patients worldwide and is characterized…
